Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

A common variant near TGFBR3 is associated with primary open angle glaucoma.

Li Z, Allingham RR, Nakano M, Jia L, Chen Y, Ikeda Y, Mani B, Chen LJ, Kee C, Garway-Heath DF, Sripriya S, Fuse N, Abu-Amero KK, Huang C, Namburi P, Burdon K, Perera SA, Gharahkhani P, Lin Y, Ueno M, Ozaki M, Mizoguchi T, Krishnadas SR, Osman EA, Lee MC, Chan AS, Tajudin LS, Do T, Goncalves A, Reynier P, Zhang H, Bourne R, Goh D, Broadway D, Husain R, Negi AK, Su DH, Ho CL, Blanco AA, Leung CK, Wong TT, Yakub A, Liu Y, Nongpiur ME, Han JC, Hon DN, Shantha B, Zhao B, Sang J, Zhang N, Sato R, Yoshii K, Panda-Jonas S, Ashley Koch AE, Herndon LW, Moroi SE, Challa P, Foo JN, Bei JX, Zeng YX, Simmons CP, Bich Chau TN, Sharmila PF, Chew M, Lim B, Tam PO, Chua E, Ng XY, Yong VH, Chong YF, Meah WY, Vijayan S, Seongsoo S, Xu W, Teo YY, Cooke Bailey JN, Kang JH, Haines JL, Cheng CY, Saw SM, Tai ES; ICAARE-Glaucoma Consortium; NEIGHBORHOOD Consortium, Richards JE, Ritch R, Gaasterland DE, Pasquale LR, Liu J, Jonas JB, Milea D, George R, Al-Obeidan SA, Mori K, Macgregor S, Hewitt AW, Girkin CA, Zhang M, Sundaresan P, Vijaya L, Mackey DA, Wong TY, Craig JE, Sun X, Kinoshita S, Wiggs JL, Khor CC, Yang Z, Pang CP, Wang N, Hauser MA, Tashiro K, Aung T, Vithana EN.

Hum Mol Genet. 2015 Jul 1;24(13):3880-92. doi: 10.1093/hmg/ddv128. Epub 2015 Apr 10.

2.

Longitudinal changes in peripapillary atrophy in the ocular hypertension treatment study: a case-control assessment.

Savatovsky E, Mwanza JC, Budenz DL, Feuer WJ, Vandenbroucke R, Schiffman JC, Anderson DR; Ocular Hypertension Treatment Study.

Ophthalmology. 2015 Jan;122(1):79-86. doi: 10.1016/j.ophtha.2014.07.033. Epub 2014 Sep 7.

3.

Investigation of known genetic risk factors for primary open angle glaucoma in two populations of African ancestry.

Liu Y, Hauser MA, Akafo SK, Qin X, Miura S, Gibson JR, Wheeler J, Gaasterland DE, Challa P, Herndon LW; International Consortium of African Ancestry REsearch in Glaucoma, Ritch R, Moroi SE, Pasquale LR, Girkin CA, Budenz DL, Wiggs JL, Richards JE, Ashley-Koch AE, Allingham RR.

Invest Ophthalmol Vis Sci. 2013 Sep 17;54(9):6248-54. doi: 10.1167/iovs.13-12779.

4.

Series length used during trend analysis affects sensitivity to changes in progression rate in the ocular hypertension treatment study.

Gardiner SK, Demirel S, De Moraes CG, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA; Ocular Hypertension Treatment Study Group.

Invest Ophthalmol Vis Sci. 2013 Feb 15;54(2):1252-9. doi: 10.1167/iovs.12-10218.

5.

GALC deletions increase the risk of primary open-angle glaucoma: the role of Mendelian variants in complex disease.

Liu Y, Gibson J, Wheeler J, Kwee LC, Santiago-Turla CM, Akafo SK, Lichter PR, Gaasterland DE, Moroi SE, Challa P, Herndon LW, Girkin CA, Budenz DL, Richards JE, Allingham RR, Hauser MA.

PLoS One. 2011;6(11):e27134. doi: 10.1371/journal.pone.0027134. Epub 2011 Nov 4. Erratum in: PLoS One. 2014;9(7):e103197.

6.

The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.

Kim J, Dally LG, Ederer F, Gaasterland DE, VanVeldhuisen PC, Blackwell B, Sullivan EK, Prum B, Shafranov G, Beck A, Spaeth GL; AGIS Investigators.

Ophthalmology. 2004 Nov;111(11):2109-16.

PMID:
15522379
7.

Regarding assessing G-Probe function.

Gaasterland DE.

Eye (Lond). 2003 Mar;17(2):123-4. No abstract available.

PMID:
12640395
8.

Neural networks to identify glaucomatous visual field progression.

Lin A, Hoffman D, Gaasterland DE, Caprioli J.

Am J Ophthalmol. 2003 Jan;135(1):49-54.

PMID:
12504697
9.

Baseline visual field characteristics in the ocular hypertension treatment study.

Johnson CA, Keltner JL, Cello KE, Edwards M, Kass MA, Gordon MO, Budenz DL, Gaasterland DE, Werner E; Ocular Hypertension Study Group.

Ophthalmology. 2002 Mar;109(3):432-7.

PMID:
11874743
10.

The Advanced Glaucoma Intervention Study (AGIS): 10. Variability among academic glaucoma subspecialists in assessing optic disc notching.

Gaasterland DE, Blackwell B, Dally LG, Caprioli J, Katz LJ, Ederer F; Advanced Glaumoca Intervention Study Investigators.

Trans Am Ophthalmol Soc. 2001;99:177-84; discussion 184-5.

11.

Glaucoma care in Olmsted County, Minnesota, 1965-1980: filtering surgery and vision outcomes.

Gaasterland DE.

Arch Ophthalmol. 1999 Sep;117(9):1236-7. Review. No abstract available.

PMID:
10496397
12.

The Advanced Glaucoma Intervention Study (AGIS): 5. Encapsulated bleb after initial trabeculectomy.

Schwartz AL, Van Veldhuisen PC, Gaasterland DE, Ederer F, Sullivan EK, Cyrlin MN.

Am J Ophthalmol. 1999 Jan;127(1):8-19.

PMID:
9932993
13.

Effect of fiberoptic diameter in diode laser transscleral cyclophotocoagulation in human autopsy eyes.

Aventuro JA, Gaasterland DE, Buzawa D.

J Glaucoma. 1998 Oct;7(5):349-52.

PMID:
9786565
14.

Response of filtered eyes to digital ocular pressure.

Kane H, Gaasterland DE, Monsour M.

Ophthalmology. 1997 Feb;104(2):202-6.

PMID:
9052623
16.

The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients.

Ederer F, Gaasterland DE, Sullivan EK; AGIS Investigators.

Control Clin Trials. 1994 Aug;15(4):299-325.

PMID:
7956270
17.

Initial experience with a new method of laser transscleral cyclophotocoagulation for ciliary ablation in severe glaucoma.

Gaasterland DE, Pollack IP.

Trans Am Ophthalmol Soc. 1992;90:225-43; discussion 243-6. No abstract available.

18.

Comparison of analytic algorithms for detecting glaucomatous visual field loss.

Katz J, Sommer A, Gaasterland DE, Anderson DR.

Arch Ophthalmol. 1991 Dec;109(12):1684-9.

PMID:
1841576
19.

Treatment trials of glaucoma suspects.

Javitt JC, Gaasterland DE, Street DA.

Ophthalmology. 1991 Oct;98(10):1483-5. No abstract available.

PMID:
1961628
20.

Endocapsular hematoma. Description and treatment of a unique form of postoperative hemorrhage.

Hagan JC 3rd, Gaasterland DE.

Arch Ophthalmol. 1991 Apr;109(4):514-8.

PMID:
2012552

Supplemental Content

Loading ...
Support Center